David Barry
Interventional Cardiology · Wynnewood, PANPI 1124559448
Payments from drug & device makers
What this record shows
This record is dominated by grants: $19,000 of the $26,153 with a category attached, or 72.6%. Medtronic accounts for 81.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $16,454 and has fallen 70.6% since, to $4,844 in 2025.
Across 116 payments — averaging $226.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$21K
- Abbott$2K
- W. L. Gore & Associates, Inc.$2K
- Boston Scientific$215
- AstraZeneca$189
- E.r. Squibb & Sons, L.L.C.$106
- plus $613 from 13 others
What the payments were for
- Grants$19,00073%
- Travel & lodging$3,59714%
- Food & beverage$3,21512%
- Education$3421%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 33 | $21,483 |
| Abbott | 21 | $2,054 |
| W. L. Gore & Associates, Inc. | 25 | $1,562 |
| Boston Scientific | 3 | $215 |
| AstraZeneca | 6 | $189 |
| E.r. Squibb & Sons, L.L.C. | 4 | $106 |
| Imperative Care, Inc | 1 | $78 |
| Cardiovascular Systems Inc. | 2 | $71 |
| Pfizer | 5 | $68 |
| Corcym Inc | 1 | $67 |
| Getinge USA Sales, LLC | 3 | $67 |
| Edwards Lifesciences | 2 | $48 |
| Johnson & Johnson | 2 | $39 |
| Boehringer Ingelheim | 2 | $39 |
| Angiodynamics, Inc. | 2 | $34 |
| Amgen | 1 | $32 |
| Abiomed | 1 | $32 |
| Biotronik Inc. | 1 | $20 |
| Lantheus Medical Imaging, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$16,462
- TRICLIP$1,355
- GORE CARDIOFORM ASD Occluder$736
- GORE CARDIOFORM Septal Occluder$308
- Resolute$240
- AMPLATZER$181
- ONYX FRONTIER$161
- FARXIGA$111
How this compares
$26,221 in reported general payments places this provider in the 80th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 24 | $320 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Wynnewood
- William GrayWynnewood$753K
- Eric GnallWynnewood$183K
- Timothy ShapiroWynnewood$96K
- Hamza HafeezWynnewood$32K
- Nishant SethiScranton$1.3M
- Matthew BeckerErie$1M
- Jon GeorgePhiladelphia$637K
- Shailendra SinghAllentown$470K
- Sanjog KalraPhiladelphia$444K
- James HarveyChambersburg$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.